V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 330001385 | 330000783 | 1.78 | 99.5 | Neo-adjuvant (N) | 2014-03-28 | 2014-04-19 | Cisplatin + Docetaxel +Fluorouracil | N | null | 330003509 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001386 | 330000783 | null | 67.6 | Adjuvant (A) | 2014-03-14 | 2014-04-13 | Cisplatin | 02 | Y | 330003509 | CISPLATIN |
| 330001387 | 330000784 | 1.66 | 79 | Curative (C) | 2017-06-16 | 2017-06-18 | CISPLATIN + DOCETAXEL + FLUOROURACIL | null | N | 330003515 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001388 | 330006465 | 1.77 | 16.45 | Neo-adjuvant (N) | null | 2013-09-14 | Cisplatin + Docetaxel +Fluorouracil | null | N | 330003517 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001389 | 330000785 | null | 94 | Curative (C) | 2014-10-24 | 2014-11-12 | CNS Medbl HR Etoposide | N | null | 330003518 | NOT MATCHED |
| 330001390 | 330000786 | null | 90.3 | Neo-adjuvant (N) | 2017-07-21 | 2017-07-31 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | null | 330003521 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001391 | 330000786 | 1.78 | 75 | Neo-adjuvant (N) | 2016-02-18 | 2016-02-24 | CISPLATIN + DOCETAXEL + FLUOROURACIL | null | N | 330003521 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001392 | 330000786 | 1.62 | 10.4 | Neo-adjuvant (N) | null | 2017-06-22 | Cisplatin + Docetaxel +Fluorouracil | 2 | N | 330003521 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001393 | 330000786 | null | 8.7 | Curative (C) | null | 2015-09-20 | Cisplatin | N | Y | 330003521 | CISPLATIN |
| 330001394 | 330000786 | 1.63 | 4.3 | Neo-adjuvant (N) | 2013-11-28 | 2013-11-29 | Cisplatin + Docetaxel +Fluorouracil | N | N | 330003521 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001395 | 330000787 | 1.75 | 118 | Curative (C) | 2014-07-07 | 2014-07-22 | Cisplatin 7 day | N | N | 330003530 | CISPLATIN |
| 330001396 | 330000787 | 0 | 83 | Curative (C) | 2017-06-30 | 2017-07-01 | Trial Unspecified | Y | N | 330003530 | TRIAL |
| 330001397 | 330000787 | 1.67 | null | Curative (C) | 2017-10-03 | 2017-10-03 | Cisplatin + Docetaxel +Fluorouracil | N | N | 330003530 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001398 | 330000788 | 1.32 | 49.2 | Neo-adjuvant (N) | null | 2013-06-11 | Cisplatin + Docetaxel +Fluorouracil | 2 | null | 330003536 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001399 | 330000789 | 1.6 | 54.7 | Curative (C) | 2016-06-02 | 2016-06-24 | Cisplatin 7 day | null | N | 330003540 | CISPLATIN |
| 330001400 | 330000789 | 1.54 | 11.3 | Neo-adjuvant (N) | 2014-09-20 | 2014-09-20 | Cisplatin + Docetaxel +Fluorouracil | N | null | 330003540 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001401 | 330000790 | 1.9 | 70.1 | Neo-adjuvant (N) | 2014-05-17 | 2014-05-19 | Cisplatin + Docetaxel +Fluorouracil | N | N | 330003543 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001402 | 330000790 | 1.72 | 68.6 | null | 2015-01-20 | 2015-02-12 | Cisplatin 7 day | 01 | N | 330003543 | CISPLATIN |
| 330001403 | 330000790 | 1.84 | 18.9 | Curative (C) | 2013-01-16 | 2013-01-17 | NB HRNBL | Y | N | 330003543 | NOT MATCHED |
| 330001404 | 330000791 | 1.62 | 54.4 | Neo-adjuvant (N) | null | 2016-11-16 | Cisplatin + Docetaxel +Fluorouracil | N | N | 330003549 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001405 | 330000792 | null | 74 | Curative (C) | 2014-11-04 | 2014-11-06 | CYCLOPHOSPHAMIDE + RITUXIMAB + prednisolone | N | N | 330003551 | NOT MATCHED |
| 330001406 | 330000793 | 1.57 | 69.3 | Neo-adjuvant (N) | 2013-06-18 | 2013-06-18 | CISPLATIN + DOCETAXEL + FLUOROURACIL | null | N | 330003555 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001407 | 330000793 | 1.83 | 68.4 | Neo-adjuvant (N) | 2013-06-04 | 2013-06-04 | Cisplatin + Docetaxel +Fluorouracil | N | null | 330003555 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001408 | 330000794 | 0 | 72 | Curative (C) | 2015-04-05 | 2015-04-11 | NB HRNBL-1 COJEC Ind COURSE A | Y | N | 330003559 | NOT MATCHED |
| 330001409 | 330000794 | 1.73 | 51.9 | Curative (C) | null | 2013-03-22 | Cisplatin | null | Y | 330003559 | CISPLATIN |
| 330001410 | 330000795 | 1.65 | 67 | Neo-adjuvant (N) | 2016-12-01 | 2016-12-08 | Cisplatin + Docetaxel +Fluorouracil | N | N | 330003565 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001411 | 330000795 | 1.75 | 65 | Curative (C) | 2015-03-02 | 2015-03-03 | Cisplatin | N | Y | 330003565 | CISPLATIN |
| 330001412 | 330000795 | null | 66.9 | Curative (C) | 2016-08-30 | 2016-08-30 | EW EuroEwing 2012 Arm B VDC | 2 | N | 330003565 | TRIAL |
| 330001413 | 330000795 | 1.23 | 70.6 | Curative (C) | 2016-03-14 | 2016-11-18 | NB HRNBL-1 COJEC Ind COURSE B | null | Y | 330003565 | NOT MATCHED |
| 330001414 | 330000796 | 1.72 | 60.2 | Curative (C) | 2013-10-03 | 2013-10-22 | Cisplatin | 02 | Y | 330003569 | CISPLATIN |
| 330001415 | 330000797 | 1.77 | 7.5 | Curative (C) | 2015-08-03 | 2015-08-10 | Cisplatin | N | N | 330003570 | CISPLATIN |
| 330001416 | 330000798 | 1.52 | 67.25 | Curative (C) | 2016-02-09 | 2016-02-15 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | 330003572 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001417 | 330000799 | 1.79 | null | Neo-adjuvant (N) | null | 2017-06-02 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | 330003574 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001418 | 330000800 | 1.7 | 26.6 | Curative (C) | 2013-12-26 | 2014-01-25 | Cisplatin 7 day | N | Y | 330003578 | CISPLATIN |
| 330001419 | 330000800 | 1.13 | null | Curative (C) | 2017-12-04 | 2017-12-11 | NB HRNBL | null | Y | 330003578 | NOT MATCHED |
| 330001420 | 330000801 | 1.73 | null | Curative (C) | 2015-03-27 | 2015-03-27 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | null | 330003585 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001421 | 330000801 | 1.81 | null | Curative (C) | 2013-06-05 | 2013-06-08 | Cisplatin 7 day | N | Y | 330003585 | CISPLATIN |
| 330001422 | 330000802 | 1.72 | 106 | null | 2014-07-13 | 2014-07-29 | Cisplatin + Docetaxel +Fluorouracil | N | N | 330003588 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001423 | 330000802 | null | 72.1 | Curative (C) | 2017-04-20 | 2017-05-19 | Cisplatin | N | N | 330003588 | CISPLATIN |
| 330001424 | 330000802 | 1.32 | null | Curative (C) | 2013-01-22 | 2013-02-07 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | 330003588 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001425 | 330011166 | null | 53 | Adjuvant (A) | 2015-10-15 | 2015-10-18 | Cisplatin | N | N | 330003594 | CISPLATIN |
| 330001426 | 330012090 | 1.72 | 55.5 | Palliative (P) | 2013-02-16 | 2013-03-08 | Cisplatin + Docetaxel +Fluorouracil | null | N | 330003597 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001427 | 330012090 | 1.63 | 45.9 | Adjuvant (A) | null | 2014-03-17 | Cisplatin | N | Y | 330003597 | CISPLATIN |
| 330001428 | 330012090 | 0 | 78.9 | Palliative (P) | 2018-04-16 | 2018-04-17 | Trial Unspecified | 01 | N | 330003597 | TRIAL |
| 330001431 | 330000804 | 1.8 | null | Curative (C) | 2013-06-15 | 2013-06-16 | NB HRNBL-1 Isotretinoin | Y | N | 330003608 | NOT MATCHED |
| 330001432 | 330000805 | 0 | 50.2 | Curative (C) | 2016-02-10 | 2016-02-13 | CYTARABINE + DAUNORUBICIN + VINCRISTINE | Y | N | 330003611 | NOT MATCHED |
| 330001433 | 330000805 | 1.67 | 56 | Neo-adjuvant (N) | null | 2016-09-09 | Cisplatin + Docetaxel +Fluorouracil | 2 | N | 330003611 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001434 | 330000806 | 1.76 | 77.2 | Palliative (P) | 2014-12-28 | 2015-01-09 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | 330003615 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001435 | 330006478 | 1.8 | 59 | Curative (C) | 2015-02-10 | 2015-03-20 | Cisplatin 7 day | null | Y | 330003619 | CISPLATIN |
| 330001436 | 330009503 | 1.61 | 7.7 | Curative (C) | 2014-12-18 | 2015-01-10 | Cisplatin 7 day | N | N | 330003626 | CISPLATIN |